A Single Center, Open Label, Randomized Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 12 Aug 2013 Status changed from not yet recruiting to completed.
- 01 Jun 2013 Primary endpoint 'Apolipoprotein-B:apolipoprotein-AI-ratio' has not been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History